Physician profile
Brian R Hamlin
NPI 1891705521
$51,335.77
in general payments reported to CMS, 2019-2025
13 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2021: $19K · 2022: $5,756 · 2023: $7,537 · 2024: $1,476 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,220 · Food and Beverage: $2,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,220.00 |
| Food and Beverage | $2,302.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $30,743.82 | 2019-2024 | Real Intelligence, Engage Partial Knee System, Pico 7 |
| Bodycad USA Corp | $10,498.43 | 2019-2021 | |
| Medical Device Business Services, INC. | $6,587.46 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $1,114.03 | 2019-2025 | Persona |
| Depuy Synthes Sales INC. | $733.36 | 2022-2025 | |
| Stryker Corporation | $544.90 | 2022-2025 | Mako, Triathlon |
| Depuy Synthes Products, INC. | $488.96 | 2022 | |
| Innovation Technologies INC | $271.28 | 2021-2024 | Irrisept |
| Medacta USA, INC. | $133.00 | 2024 | |
| Davol INC. | $105.00 | 2022 | |
| Lima USA, INC. | $84.46 | 2019 | |
| Ethicon US, LLC | $16.27 | 2025 | Evarrest, Stratafix, Ethicon |
| Solventum Corporation | $14.80 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hamlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.